Integer (ITGR) Competitors $107.03 -1.04 (-0.96%) As of 12:49 PM Eastern This is a fair market value price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock ITGR vs. BDSX, ELV, BAX, MASI, GMED, TFX, ATEC, ATRC, IART, and OFIXShould you be buying Integer stock or one of its competitors? The main competitors of Integer include Biodesix (BDSX), Elevance Health (ELV), Baxter International (BAX), Masimo (MASI), Globus Medical (GMED), Teleflex (TFX), Alphatec (ATEC), AtriCure (ATRC), Integra LifeSciences (IART), and Orthofix Medical (OFIX). These companies are all part of the "medical" sector. Integer vs. Its Competitors Biodesix Elevance Health Baxter International Masimo Globus Medical Teleflex Alphatec AtriCure Integra LifeSciences Orthofix Medical Biodesix (NASDAQ:BDSX) and Integer (NYSE:ITGR) are both medical companies, but which is the better stock? We will contrast the two companies based on the strength of their analyst recommendations, profitability, media sentiment, institutional ownership, risk, dividends, valuation and earnings. Do insiders & institutionals hold more shares of BDSX or ITGR? 21.0% of Biodesix shares are owned by institutional investors. Comparatively, 99.3% of Integer shares are owned by institutional investors. 30.1% of Biodesix shares are owned by insiders. Comparatively, 2.2% of Integer shares are owned by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company will outperform the market over the long term. Which has stronger valuation and earnings, BDSX or ITGR? Integer has higher revenue and earnings than Biodesix. Biodesix is trading at a lower price-to-earnings ratio than Integer, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioBiodesix$71.32M0.94-$42.93M-$0.29-1.58Integer$1.79B2.09$119.90M$2.2747.15 Do analysts prefer BDSX or ITGR? Biodesix currently has a consensus target price of $1.75, suggesting a potential upside of 282.93%. Integer has a consensus target price of $140.25, suggesting a potential upside of 31.04%. Given Biodesix's higher probable upside, analysts plainly believe Biodesix is more favorable than Integer.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Biodesix 0 Sell rating(s) 1 Hold rating(s) 4 Buy rating(s) 0 Strong Buy rating(s) 2.80Integer 0 Sell rating(s) 1 Hold rating(s) 7 Buy rating(s) 1 Strong Buy rating(s) 3.00 Is BDSX or ITGR more profitable? Integer has a net margin of 4.61% compared to Biodesix's net margin of -53.66%. Integer's return on equity of 12.27% beat Biodesix's return on equity.Company Net Margins Return on Equity Return on Assets Biodesix-53.66% -269.67% -43.94% Integer 4.61%12.27%6.23% Which has more risk & volatility, BDSX or ITGR? Biodesix has a beta of 0.99, indicating that its stock price is 1% less volatile than the S&P 500. Comparatively, Integer has a beta of 1.02, indicating that its stock price is 2% more volatile than the S&P 500. Does the media favor BDSX or ITGR? In the previous week, Integer had 6 more articles in the media than Biodesix. MarketBeat recorded 7 mentions for Integer and 1 mentions for Biodesix. Biodesix's average media sentiment score of 1.87 beat Integer's score of 1.59 indicating that Biodesix is being referred to more favorably in the media. Company Overall Sentiment Biodesix Very Positive Integer Very Positive SummaryInteger beats Biodesix on 14 of the 17 factors compared between the two stocks. Get Integer News Delivered to You Automatically Sign up to receive the latest news and ratings for ITGR and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding ITGR and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart ITGR vs. The Competition Export to ExcelMetricIntegerMED INSTRUMENTS IndustryMedical SectorNYSE ExchangeMarket Cap$3.75B$6.90B$5.75B$21.26BDividend YieldN/A1.30%3.95%3.53%P/E Ratio47.1526.2830.7329.24Price / Sales2.0955.97457.9453.45Price / Cash12.1821.6137.7623.64Price / Book2.206.9310.125.37Net Income$119.90M$176.42M$3.27B$996.59M7 Day Performance0.29%3.30%3.58%2.96%1 Month Performance-0.92%-1.71%4.76%2.83%1 Year Performance-16.09%9.69%45.41%12.71% Integer Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)ITGRInteger3.8586 of 5 stars$107.03-1.0%$140.25+31.0%-15.0%$3.75B$1.79B47.1511,000Positive NewsBDSXBiodesix3.5958 of 5 stars$0.43+7.2%$1.75+311.8%-74.6%$58.11M$71.32M-1.47220Positive NewsELVElevance Health4.8901 of 5 stars$310.03+0.1%$413.81+33.5%-43.6%$69.71B$177.01B13.19104,200Positive NewsBAXBaxter International4.7239 of 5 stars$23.61-2.4%$30.11+27.5%-35.2%$12.42B$10.64B-78.7038,000MASIMasimo4.3457 of 5 stars$153.93+0.0%$193.60+25.8%+22.3%$8.36B$2.09B-18.075,600Positive NewsAnalyst RevisionGMEDGlobus Medical4.9488 of 5 stars$60.27-0.5%$87.64+45.4%-14.2%$8.18B$2.52B23.185,300Positive NewsTFXTeleflex4.7551 of 5 stars$120.24-0.4%$141.57+17.7%-46.5%$5.33B$3.05B28.2914,100Positive NewsATECAlphatec4.0092 of 5 stars$15.86+1.0%$18.50+16.6%+156.0%$2.32B$611.56M-14.04700Positive NewsATRCAtriCure2.9495 of 5 stars$35.62+0.5%$50.89+42.9%+45.7%$1.76B$465.31M-46.261,300Positive NewsInsider TradeIARTIntegra LifeSciences4.0794 of 5 stars$14.05-1.0%$18.63+32.6%-27.5%$1.11B$1.61B-2.154,396OFIXOrthofix Medical2.8947 of 5 stars$14.51+2.0%$21.50+48.2%-15.2%$562M$799.49M-4.581,616News Coverage Related Companies and Tools Related Companies BDSX Alternatives ELV Alternatives BAX Alternatives MASI Alternatives GMED Alternatives TFX Alternatives ATEC Alternatives ATRC Alternatives IART Alternatives OFIX Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NYSE:ITGR) was last updated on 8/28/2025 by MarketBeat.com Staff From Our PartnersBuffett, Gates and Bezos Quietly Dumping Stocks—Here's WhyImagine a bull market so powerful, every single investor became a millionaire. Not by finding the next NVIDIA ...Banyan Hill Publishing | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | SponsoredWhat Steve Bannon revealed about Trump’s gold playA Trump advisor just said 3 words that could reset the dollar. It’s a gold move nobody saw coming—and your ...Reagan Gold Group | SponsoredThe Robotics Revolution has arrived … and one $7 stock could take off as a result.Something big is brewing in Washington. According to my research, an executive order from President Trump c...Weiss Ratings | SponsoredChase, Bank of America, Wells Fargo Preparing for BIG ChangeThanks to this brand-new law #S.1582 signed by President Trump… Jeff Brown believes the largest banks in Am...Brownstone Research | Sponsored“Sell Nvidia before earnings”Eric Fry just went live with one of his most controversial calls yet: “Sell Nvidia.” While Wall Street has bee...InvestorPlace | SponsoredBONUS GUIDE - Ben Stein Prepares For the Next Financial CrisisWith inflation high, debt soaring, and global tensions rising, a financial storm may be brewing. Economist ...Goldco Precious Metals | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Integer Holdings Corporation Please log in to your account or sign up in order to add this asset to your watchlist. Share Integer With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.